Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Recruiting now · Not applicable

Conditions studied: Vertebral Fracture, Multiple Myeloma

In brief

Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).

Key facts

Study ID

NCT04533217

Run by

Spine Centre of Southern Denmark

People needed

90

Starts

2021-03-29

Expected to finish

2026-07-31

Last updated by the study team

2024-12-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• known multiple myeloma
• verified lesion(s) between Th6-L5
• 4 or less fractures
• relevant pain in 3 months or less
• vertebroplasty can be performed in one procedure
• VAS 5 or more

You may not qualify if…

• presence of neurologic deficit
• psychological or psychiatric disorder hat is expected to interfere with compliance

Where it is running

• Center for Spine Surgery and Research — Middelfart, Region Syddanmark, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.